Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China flag China · Delayed Price · Currency is CNY
5.23
+0.03 (0.58%)
Sep 23, 2026, 3:04 PM CST

SHE:300318 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
114.37121.8377.26104.93113.639.39
Short-Term Investments
19.95-----
Cash & Short-Term Investments
134.32121.8377.26104.93113.639.39
Cash Growth
-20.52%57.69%-26.36%-7.64%188.36%-11.66%
Accounts Receivable
116.8193.2459.3453.982.4194.85
Other Receivables
42.7658.8367.1596.4758.03106.79
Receivables
159.57152.07126.49150.37140.43201.64
Inventory
1,2061,1441,011854.56870.52820.95
Prepaid Expenses
-0.09-0.080.030.01
Other Current Assets
12.378.611.3114.6915.5517.56
Total Current Assets
1,5121,4271,2261,1251,1401,080
Property, Plant & Equipment
1,5241,5041,5041,4781,3921,227
Long-Term Investments
9.619.6110.9111.8216.8116.81
Goodwill
786.27786.27786.27786.27786.27802.19
Other Intangible Assets
368.3374.88346.61297.33310.43370.84
Long-Term Deferred Tax Assets
4.815.833.63.682.722.38
Long-Term Deferred Charges
70.9980.5512490.3473.356.25
Other Long-Term Assets
114.4116.33123.64134.23186.32135.03
Total Assets
4,3914,3044,1263,9263,9083,690

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
216.46220.4229.03261.19302.37227.13
Accrued Expenses
53.6567.9962.556686.9960.89
Short-Term Debt
235.76404.56451.94365.51423.47434.89
Current Portion of Long-Term Debt
277.03237.69163.654.3628.3523.38
Current Portion of Leases
9.0711.057.566.763.562.53
Current Income Taxes Payable
0.72.113.9114.118.362.12
Current Unearned Revenue
18.8518.6720.2222.740.321.59
Other Current Liabilities
903.19568.29275.13274.23229.441,762
Total Current Liabilities
1,7151,5311,2141,0651,1232,535
Long-Term Debt
367.18436.96389.88340.93313.6883.58
Long-Term Leases
34.6434.9838.2339.4918.938.31
Long-Term Unearned Revenue
21.821.3328.5631.6217.5117.75
Long-Term Deferred Tax Liabilities
100.66101.68103.45107.29108.94110.87
Other Long-Term Liabilities
2.752.542.381.292.622.03
Total Liabilities
2,2422,1281,7761,5851,5852,757

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
816.9816.9816.9816.9816.9816.9
Additional Paid-In Capital
751.76751.76754.22754.22754.22260.76
Retained Earnings
-302.42-286.82-194.89-204.14-179.21-100.68
Comprehensive Income & Other
5.523.342.462.561.42-2.23
Total Common Equity
1,2721,2851,3791,3701,393974.75
Minority Interest
877.09890.81970.44971.01930.17-42.01
Shareholders' Equity
2,1492,1762,3492,3412,323932.75
Total Liabilities & Equity
4,3914,3044,1263,9263,9083,690

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
923.681,1251,051807.04787.99552.68
Net Cash (Debt)
-789.36-1,003-973.95-702.11-674.39-513.29
Net Cash Growth
------
Net Cash Per Share
-0.97-1.23-1.19-0.86-0.83-0.63
Filing Date Shares Outstanding
816.9816.9816.9816.9816.9816.9
Total Common Shares Outstanding
816.9816.9816.9816.9816.9816.9
Working Capital
-202.92-103.7312.3959.7817.29-1,455
Book Value Per Share
1.561.571.691.681.711.19
Tangible Book Value
117.19124.03245.81285.94296.63-198.28
Tangible Book Value Per Share
0.140.150.300.350.36-0.24
Buildings
564.96564.49558.46538.42527.25523.98
Machinery
652.51649.63633.52639.97649.6629.9
Construction In Progress
1,002955.78933.12888.36809.66629.95